About Senzo
Senzo is a Healthcare company based in San Francisco (United States) founded in 2013. Point-of-care diagnostic devices for infectious diseases are developed. Senzo has raised $9.6 million across 5 funding rounds from investors including HHS, Wellness Coaches and BioAdvance. The company has 13 employees. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Viral. Its legal entity is SENZO HEALTH LIMITED. Its competitors include Hememics Biotechnologies, Quantalife and IncellDx; 3 of its 3 listed competitors have raised funding.
Company details
The company was founded in 2013 in San Francisco, United States, within the health diagnostics sector. Portable rapid test devices are developed for detecting infectious diseases at the point of care. The Amplified Lateral Flow (ALF) device has been created as an alternative to PCR antigen tests. Diseases such as COVID-19, Flu AB, Tuberculosis, HIV, Hepatitis C, and C. difficile are targeted by these devices for on-site viral detection.
- Total Equity Funding$9.6M (USD)
in 5 rounds
- Latest Funding Round$1.8M (USD), Seed
Oct 2023
- InvestorsHHS
& 2 more
- Employee Count13
Funding Insights of Senzo
Senzo has successfully raised a total of $9.6M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.6M
- Total Rounds 5
- Last Round Seed — $1.8M
- First Round $3.9M
(Jun 2022)
- Investors Count 3
All 5 funding rounds of Senzo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $1.8M | Seed | – | – | – |
| Dec 2022 | $1.9M | Seed | – | BioAdvance, Wellness Coaches | – |
| Oct 2022 | $750,000 | Grant | – | – | |
| Jul 2022 | $2M | Seed | – | BioAdvance | |
| Jun 2022 | $3.9M | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Senzo
Senzo has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Wellness Coaches and BioAdvance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| bioadvance.com | ||||
Corporate health, wellness, and nutrition services are provided to businesses. | 2002 | wellnesscoachesusa.com | Blue Bell, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Senzo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Senzo
3 dated milestones of Senzo across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Senzo is founded.
- Funding First funding round of $3.9M.
- Funding Latest funding round, Seed, of $1.8M.
Competitors of Senzo
Senzo has 3 listed competitors in our database, 3 of them funded. They include Hememics Biotechnologies, Quantalife and IncellDx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hememics.com | 2009 | Gaithersburg, United States | $4.6M | 13 | Biopreservation platform for mammalian cells and biologics is developed. | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | ||
| incelldx.com | 2009 | Menlo Park, United States | $9.5M | Molecular diagnostic assays and kits for infectious diseases are developed. |
Detailed competitors of Senzo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Senzo
The website of Senzo (senzo.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 36.4% vs previous month
Top companies in Infectious Diseases
3 companies that operate in the same segment as Senzo (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 87.11 M | 4,647 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Senzo
Complete news archive for Senzo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senzo
Senzo was founded in 2013 and raised its 1st funding round 9 years after it was founded.
Senzo is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Senzo is a funded company, having raised a total of $9.6M across 5 funding rounds to date. The company's 1st funding round was a Seed of $3.9M, raised on Jun 2022.
Senzo has 13 employees.
The company was founded in 2013 in San Francisco, United States, within the health diagnostics sector. Portable rapid test devices are developed for detecting infectious diseases at the point of care. The Amplified Lateral Flow (ALF) device has been created as an alternative to PCR antigen tests. Diseases such as COVID-19, Flu AB, Tuberculosis, HIV, Hepatitis C, and C. difficile are targeted by these devices for on-site viral detection.
Senzo's top competitors include Quantalife, Hememics Biotechnologies and IncellDx.
Senzo has 3 investors. Key investors include HHS, Wellness Coaches, and BioAdvance.
Senzo operates through Senzo Health Limited.